Next report date
Report period
Q2 2024
EPS estimate
−0.10CHF
Revenue estimate
—
−43.49 MCHF
79.52 M
Om Anavex Life Sciences Corp.
Sektor
Bransch
VD
Christopher U. Missling
Webbplats
Huvudkvarter
New York
Employees (FY)
40
Grundat
2004
FIGI
BBG00LVD76F3
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
